Atlas Trials

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

Clinical trial NCT03412955 · UNKNOWN

Trial details

NCT number
NCT03412955
Sponsor
Tan Tock Seng Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-03-08
Primary completion
2020-04-30
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.